Probe Targets FDA Drug Approvals (The Tampa Tribune)
The government's watchdog agency is investigating whether the Food and Drug Administration's drug-review process cleared two blockbuster medications without sufficient proof of their safety or effectiveness.

Endo Licenses U.S. Rights For Voltaren(R) Gel -- The First FDA-Approved Topical Treatment For Relief Of Osteoarthritis ... (Medical News Today)
Endo Pharmaceuticals Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) and a market leader in pain management, announced that it has entered into a licensing agreement with Novartis to obtain the exclusive U.S. marketing rights for the prescription medicine Voltaren Gel (diclofenac sodium topical gel) 1%.

FDA approves Aloxi injection for prevention of postoperative nausea and vomiting (News-Medical-Net)
Eisai Corporation of North America, its U.S. subsidiary, MGI PHARMA, INC., and Helsinn Healthcare SA today announced that the U.S. Food and Drug Administration (FDA) has approved Aloxi (palonosetron hydrochloride) injection for the prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery.